Position in SVTR
Snapshot 2026-10-25- Startup SignalsTop 50%↓58
- Life SciencesRankedof 247↓5
- BCI#7of 18–
About
Neurosoft Bioelectronics, founded in 2020 in Geneva/Lausanne, Switzerland, develops flexible, stretchable, non-penetrating brain-computer interfaces and neural implant electrodes for recording and stimulating neural activity on the brain surface.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 4
Founders / team· 1
Funding history
- 2026-05Seed$8M
Investors · IAG Capital Partners, Connecticut Innovations, Skybound Venture Capital, PL CapitalSource · SVTR Weekly #158 ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M
United States
BusinessLatest roundTotal raisedDate- Subsense
Nanoparticle-based non-surgical BCI for implant-free recording and modulation of neural activity
Seed · $10M · 2025-12
$10M - Axoft
Implantable brain-computer interfaces using biomimetic materials, with flexible neural electronics for high-resolution neural recording and stimulation
Series A · $60M · 2026-05
$60M - Echo Neurotechnologies
Brain-computer interfaces that let patients with severe disabilities control devices with their thoughts via implanted electrodes
Series A · $50M · 2025-02
$50M
China
BusinessLatest roundTotal raisedDate- 芯生视界
Invasive brain-computer interface system, a 10,000-channel all-in-one implantable "neural GPU"
Seed · $14M · 2026-06
$14M - SiClink
Founded in December 2025, SiClink is an implantable brain-computer interface company founded by ShanghaiTech University researcher Dr. He Fei. It develops semiconductor hollow flexible neural electrodes and a proprietary saline-based stiffness-modulation minimally invasive implantation process to build high-bandwidth, low-latency, long-term stable bidirectional brain-machine interfaces, starting with visual reconstruction.
— - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M
Europe
BusinessLatest roundTotal raisedDate- InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M - MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
—
Other / unspecified
BusinessLatest roundTotal raisedDate- 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - Brain.space
Non-invasive brain monitoring platform with real-time neural data analysis
Series A · $11M · 2025-03
$11M - Vital Biosciences
Diagnostic technology developing the "revolutionary" blood test VitalOne
Undisclosed · $48M · 2023-07
$48M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 1 in Western Europe
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 3 in Western Europe
Request intro →Alumni Ventures
12 Life Sciences deals in the last 24 months · 8 at a nearby stage · 1 in Western Europe
Request intro →Accel
12 Life Sciences deals in the last 24 months · 8 at a nearby stage · 3 in Western Europe
Request intro →LifeX Ventures
8 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in Western Europe
Request intro →Index Ventures
8 Life Sciences deals in the last 24 months · 4 at a nearby stage · 3 in Western Europe
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.